Search

Your search keyword '"Cell Line, Tumor"' showing total 18,601 results

Search Constraints

Start Over You searched for: Descriptor "Cell Line, Tumor" Remove constraint Descriptor: "Cell Line, Tumor" Publication Year Range This year Remove constraint Publication Year Range: This year
18,601 results on '"Cell Line, Tumor"'

Search Results

1. Regulatory effect of extracellular matrix stiffness on the plasticity of human prostate cancer cells

2. Effect of regulator of ribosome synthesis 1 on proliferation and metastasis abilities of human breast cancer MDA-MB-468 cells

3. Tapirira guianensis is selectively cytotoxic, induces apoptosis to the glioblastoma and decreases tumor growth and angiogenesis in vivo

4. XPO1 Blockade with KPT-330 Promotes Apoptosis in Cutaneous T-cell Lymphoma by Activating the p53-p21 and p27 Pathways

5. Decorin Suppresses Tumor Lymphangiogenesis: A Mechanism to Curtail Cancer Progression

6. TARDBP drives T-cell acute lymphoblastic leukemia progression by binding MDM2 mRNA, involving β-catenin pathway.

7. The RNA N6-methyladenosine demethylase FTO regulates ATG5 to inhibit malignant progression of uveal melanoma.

8. Expression of the non-coding RNA nc886 facilitates the development of tyrosine kinase inhibitor resistance in EGFR-mutated non-small-cell lung cancer cells.

9. JK-1, a useful erythroleukemic cell line model to study a controlled erythroid differentiation from progenitors to terminal erythropoiesis.

10. Dual ON/OFF-switch chimeric antigen receptor controlled by two clinically approved drugs.

11. O-GlcNAcylation of enolase 1 serves as a dual regulator of aerobic glycolysis and immune evasion in colorectal cancer.

12. Optogenetically engineered Septin-7 enhances immune cell infiltration of tumor spheroids.

13. eIF4F controls ERK MAPK signaling in melanomas with BRAF and NRAS mutations.

14. Complement activation by IgG subclasses is governed by their ability to oligomerize upon antigen binding.

15. QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion.

16. WDR20 prevents hepatocellular carcinoma senescence by orchestrating the simultaneous USP12/46-mediated deubiquitination of c-Myc.

17. DMF-Bimol: Counting mRNA and Protein Molecules in Single Cells with Digital Microfluidics.

18. Intracellular Magnetic Hyperthermia Sensitizes Sorafenib to Orthotopic Hepatocellular Carcinoma Via Amplified Ferroptosis.

19. Bone Destruction-Chemotactic Osteoprogenitor Cells Deliver Liposome Nanomedicines for the Treatment of Osteosarcoma and Osteoporosis.

20. Single-Dose Physically Cross-Linked Hyaluronic Acid and Lipid Hybrid Nanoparticles Containing Cyclic Guanosine Monophosphate-Adenosine Monophosphate Eliminate Established Tumors.

21. Hollow Copper Sulfide Nanocubes Loaded with Pt(IV) Complexes for Cancer Multimodal Therapy.

22. Machine Learning Classification of Integrin-Expression-Based Magnetic Sorted SW 620 Cells by Simultaneous O-PTIR and SERS.

23. Hollow Calcium/Copper Bimetallic Amplifier for Cuproptosis/Paraptosis/Apoptosis Cancer Therapy via Cascade Reinforcement of Endoplasmic Reticulum Stress and Mitochondrial Dysfunction.

24. Mitochondria-Targeted Gold Biometallization for Photoacoustically Visualized Photothermal Cancer Therapy.

25. Cold Exposure Therapy Sensitizes Nanodrug-Mediated Radioimmunotherapy of Breast Cancer.

26. Zinc-Nickel Bimetallic Hydroxide Nanosheets Activate the Paraptosis-Pyroptosis Positive Feedback Cycle for Enhanced Tumor Immunotherapy.

27. Supramolecular palladium complexes based on guanidinium pillar[5]arene for cancer therapy.

28. Identification of Molecular Profile of Cell Membrane via Magnetic Plasmonic Nanoprobe.

29. MECOM and the PRDM gene family in uterine endometrial cancer: bioinformatics and experimental insights into pathogenesis and therapeutic potentials.

30. 5'-tRNA Gly(GCC) halves generated by IRE1α are linked to the ER stress response.

31. Caerin 1.1 and 1.9 peptides halt B16 melanoma metastatic tumours via expanding cDC1 and reprogramming tumour macrophages.

32. The mechanism of paclitaxel induced damage on placental trophoblast cells.

33. Machine learning-guided synthesis of nanomaterials for breast cancer therapy.

34. Extracellular vesicles of Clonorchis sinensis promote the malignant phenotypes of cholangiocarcinoma via NF-κB/EMT axis.

35. Deciphering STAT3's negative regulation of LHPP in ESCC progression through single-cell transcriptomics analysis.

36. Proteomic profiling reveals CEACAM6 function in driving gallbladder cancer aggressiveness through integrin receptor, PRKCD and AKT/ERK signaling.

37. ZSTK474 targeting PIK3R3 inhibits the Wilms' tumor through G0 / G1 phase arrest.

38. Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL+ leukemia stem cells.

39. Emodin regulated lactate metabolism by inhibiting MCT1 to delay non-small cell lung cancer progression.

40. Glutamine and serum starvation alters the ATP production, oxidative stress, and abundance of mitochondrial RNAs in extracellular vesicles produced by cancer cells.

41. Cationized extracellular vesicles for gene delivery.

42. Innovative N -Acridine Thiosemicarbazones and Their Zn(II) Complexes Transmetallate with Cu(II): Redox Activity and Suppression of Detrimental Oxy-Myoglobin Oxidation.

43. In Silico Design of Novel RGS2-G alpha-q Interaction Inhibitors with Anticancer Activity.

44. The influence of magnesium and manganese cations on the chemical and bioactive properties of purple and green basil.

45. Polyubiquitinated PCNA triggers SLX4-mediated break-induced replication in alternative lengthening of telomeres (ALT) cancer cells.

46. YAP activation is robust to dilution.

47. Eukaryotic initiation factor 4B is a multi-functional RNA binding protein that regulates histone mRNAs.

48. N 6 -methyladenosine enhances the expression of TGF-β-SMAD signaling family to inhibit cell growth and promote cell metastasis.

49. Protease activated receptor-1 regulates mixed lineage kinase-3 to drive triple-negative breast cancer tumorigenesis.

50. PARP1-TRIM44-MRN loop dictates the response to PARP inhibitors.

Catalog

Books, media, physical & digital resources